This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jonker, J. W.
Right arrow Articles by Schinkel, A. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jonker, J. W.
Right arrow Articles by Schinkel, A. H.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, November 2003, p. 7902-7908, Vol. 23, No. 21
0270-7306/03/$08.00+0     DOI: 10.1128/MCB.23.21.7902-7908.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Deficiency in the Organic Cation Transporters 1 and 2 (Oct1/Oct2 [Slc22a1/Slc22a2]) in Mice Abolishes Renal Secretion of Organic Cations

Johan W. Jonker, Els Wagenaar, Sven van Eijl, and Alfred H. Schinkel*

Division of Experimental Therapy, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands

Received 15 May 2003/ Returned for modification 21 July 2003/ Accepted 5 August 2003

The polyspecific organic cation transporters 1 and 2 (Oct1 and -2) transport a broad range of substrates, including drugs, toxins, and endogenous compounds. Their strategic localization in the basolateral membrane of epithelial cells in the liver, intestine (Oct1), and kidney (Oct1 and Oct2) suggests that they play an essential role in removing noxious compounds from the body. We previously showed that in Oct1-/- mice, the hepatic uptake and intestinal excretion of organic cations are greatly reduced. Since Oct1 and Oct2 have extensively overlapping substrate specificities, they might be functionally redundant. To investigate the pharmacologic and physiologic roles of these proteins, we generated Oct2 single-knockout and Oct1/2 double-knockout mice. Oct2-/- and Oct1/2-/- mice are viable and fertile and display no obvious phenotypic abnormalities. Absence of Oct2 in itself had little effect on the pharmacokinetics of tetraethylammonium (TEA), but in Oct1/2-/- mice, renal secretion of this compound was completely abolished, leaving only glomerular filtration as a TEA clearance mechanism. As a consequence, levels of TEA were substantially increased in the plasma of Oct1/2-/- mice. This study shows that Oct1 and Oct2 together are essential for renal secretion of (small) organic cations. A deficiency in these proteins may thus result in increased drug sensitivity and toxicity.


* Corresponding author. Mailing address: Division of Experimental Therapy, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. Phone: 31-20-5122046. Fax: 31-20-5122050. E-mail: a.schinkel{at}nki.nl.


Molecular and Cellular Biology, November 2003, p. 7902-7908, Vol. 23, No. 21
0022-538X/03/$08.00+0     DOI: 10.1128/MCB.23.21.7902-7908.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Tsuda, M., Terada, T., Mizuno, T., Katsura, T., Shimakura, J., Inui, K.-i. (2009). Targeted Disruption of the Multidrug and Toxin Extrusion 1 (Mate1) Gene in Mice Reduces Renal Secretion of Metformin. Mol. Pharmacol. 75: 1280-1286 [Abstract] [Full Text]  
  • Lee, W.-K., Reichold, M., Edemir, B., Ciarimboli, G., Warth, R., Koepsell, H., Thevenod, F. (2009). Organic cation transporters OCT1, 2, and 3 mediate high-affinity transport of the mutagenic vital dye ethidium in the kidney proximal tubule. Am. J. Physiol. Renal Physiol. 296: F1504-F1513 [Abstract] [Full Text]  
  • Vlaming, M. L.H., Pala, Z., van Esch, A., Wagenaar, E., de Waart, D. R., van de Wetering, K., van der Kruijssen, C. M.M., Oude Elferink, R. P.J., van Tellingen, O., Schinkel, A. H. (2009). Functionally Overlapping Roles of Abcg2 (Bcrp1) and Abcc2 (Mrp2) in the Elimination of Methotrexate and Its Main Toxic Metabolite 7-Hydroxymethotrexate In vivo. Clin. Cancer Res. 15: 3084-3093 [Abstract] [Full Text]  
  • Cheng, Y., Wright, S. H., Hooth, M. J., Sipes, I. G. (2009). Characterization of the Disposition and Toxicokinetics of N-Butylpyridinium Chloride in Male F-344 Rats and Female B6C3F1 Mice and Its Transport by Organic Cation Transporter 2. Drug Metab. Dispos. 37: 909-916 [Abstract] [Full Text]  
  • Shah, N., Khurana, S., Cheng, K., Raufman, J.-P. (2009). Muscarinic receptors and ligands in cancer. Am. J. Physiol. Cell Physiol. 296: C221-C232 [Abstract] [Full Text]  
  • Vlaming, M. L.H., Pala, Z., van Esch, A., Wagenaar, E., van Tellingen, O., de Waart, D. R., Oude Elferink, R. P.J., van de Wetering, K., Schinkel, A. H. (2008). Impact of Abcc2 (Mrp2) and Abcc3 (Mrp3) on the In vivo Elimination of Methotrexate and its Main Toxic Metabolite 7-hydroxymethotrexate. Clin. Cancer Res. 14: 8152-8160 [Abstract] [Full Text]  
  • Klaassen, C. D., Lu, H. (2008). Xenobiotic Transporters: Ascribing Function from Gene Knockout and Mutation Studies. Toxicol Sci 101: 186-196 [Abstract] [Full Text]  
  • Maeda, T., Oyabu, M., Yotsumoto, T., Higashi, R., Nagata, K., Yamazoe, Y., Tamai, I. (2007). Effect of Pregnane X Receptor Ligand on Pharmacokinetics of Substrates of Organic Cation Transporter Oct1 in Rats. Drug Metab. Dispos. 35: 1580-1586 [Abstract] [Full Text]  
  • Zhang, X., Cherrington, N. J., Wright, S. H. (2007). Molecular identification and functional characterization of rabbit MATE1 and MATE2-K. Am. J. Physiol. Renal Physiol. 293: F360-F370 [Abstract] [Full Text]  
  • Kang, H.-J., Song, I.-S., Shin, H. J., Kim, W.-Y., Lee, C.-H., Shim, J.-C., Zhou, H.-H., Lee, S. S., Shin, J.-G. (2007). Identification and Functional Characterization of Genetic Variants of Human Organic Cation Transporters in a Korean Population. Drug Metab. Dispos. 35: 667-675 [Abstract] [Full Text]  
  • Vlaming, M. L. H., Mohrmann, K., Wagenaar, E., de Waart, D. R., Elferink, R. P. J. O., Lagas, J. S., van Tellingen, O., Vainchtein, L. D., Rosing, H., Beijnen, J. H., Schellens, J. H. M., Schinkel, A. H. (2006). Carcinogen and Anticancer Drug Transport by Mrp2 in Vivo: Studies Using Mrp2 (Abcc2) Knockout Mice. J. Pharmacol. Exp. Ther. 318: 319-327 [Abstract] [Full Text]  
  • Michel, V., Yuan, Z., Ramsubir, S., Bakovic, M. (2006). Choline Transport for Phospholipid Synthesis.. Exp. Biol. Med. 231: 490-504 [Abstract] [Full Text]  
  • Saborowski, M., Kullak-Ublick, G. A., Eloranta, J. J. (2006). The Human Organic Cation Transporter-1 Gene Is Transactivated by Hepatocyte Nuclear Factor-4{alpha}. J. Pharmacol. Exp. Ther. 317: 778-785 [Abstract] [Full Text]  
  • Fullerton, M. D., Wagner, L., Yuan, Z., Bakovic, M. (2006). Impaired trafficking of choline transporter-like protein-1 at plasma membrane and inhibition of choline transport in THP-1 monocyte-derived macrophages. Am. J. Physiol. Cell Physiol. 290: C1230-C1238 [Abstract] [Full Text]  
  • Zhang, X., Shirahatti, N. V., Mahadevan, D., Wright, S. H. (2005). A Conserved Glutamate Residue in Transmembrane Helix 10 Influences Substrate Specificity of Rabbit OCT2 (SLC22A2). J. Biol. Chem. 280: 34813-34822 [Abstract] [Full Text]  
  • Tahara, H., Kusuhara, H., Endou, H., Koepsell, H., Imaoka, T., Fuse, E., Sugiyama, Y. (2005). A Species Difference in the Transport Activities of H2 Receptor Antagonists by Rat and Human Renal Organic Anion and Cation Transporters. J. Pharmacol. Exp. Ther. 315: 337-345 [Abstract] [Full Text]  
  • Bleasby, K., Hall, L. A., Perry, J. L., Mohrenweiser, H. W., Pritchard, J. B. (2005). Functional Consequences of Single Nucleotide Polymorphisms in the Human Organic Anion Transporter hOAT1 (SLC22A6). J. Pharmacol. Exp. Ther. 314: 923-931 [Abstract] [Full Text]  
  • Ishiguro, N., Saito, A., Yokoyama, K., Morikawa, M., Igarashi, T., Tamai, I. (2005). TRANSPORT OF THE DOPAMINE D2 AGONIST PRAMIPEXOLE BY RAT ORGANIC CATION TRANSPORTERS OCT1 AND OCT2 IN KIDNEY. Drug Metab. Dispos. 33: 495-499 [Abstract] [Full Text]  
  • Suhre, W. M., Ekins, S., Chang, C., Swaan, P. W., Wright, S. H. (2005). Molecular Determinants of Substrate/Inhibitor Binding to the Human and Rabbit Renal Organic Cation Transporters hOCT2 and rbOCT2. Mol. Pharmacol. 67: 1067-1077 [Abstract] [Full Text]  
  • Kato, Y., Sai, Y., Yoshida, K., Watanabe, C., Hirata, T., Tsuji, A. (2005). PDZK1 Directly Regulates the Function of Organic Cation/Carnitine Transporter OCTN2. Mol. Pharmacol. 67: 734-743 [Abstract] [Full Text]  
  • Miakotina, O. L., Agassandian, M., Shi, L., Look, D. C., Mallampalli, R. K. (2005). Adenovirus stimulates choline efflux by increasing expression of organic cation transporter-2. Am. J. Physiol. Lung Cell. Mol. Physiol. 288: L93-L102 [Abstract] [Full Text]  
  • Thomas, M. C., Tikellis, C., Kantharidis, P., Burns, W. C., Cooper, M. E., Forbes, J. M. (2004). The Role of Advanced Glycation in Reduced Organic Cation Transport Associated with Experimental Diabetes. J. Pharmacol. Exp. Ther. 311: 456-466 [Abstract] [Full Text]  
  • Wright, S. H., Evans, K. K., Zhang, X., Cherrington, N. J., Sitar, D. S., Dantzler, W. H. (2004). Functional map of TEA transport activity in isolated rabbit renal proximal tubules. Am. J. Physiol. Renal Physiol. 287: F442-F451 [Abstract] [Full Text]  
  • Wright, S. H., Dantzler, W. H. (2004). Molecular and Cellular Physiology of Renal Organic Cation and Anion Transport. Physiol. Rev. 84: 987-1049 [Abstract] [Full Text]  
  • BRAIDOTTI, G., BAUBEC, T., PAULER, F., SEIDL, C., SMRZKA, O., STRICKER, S., YOTOVA, I., BARLOW, D.P. (2004). The Air Noncoding RNA: An Imprinted cis-silencing Transcript. Cold Spring Harb Symp Quant Biol 69: 55-66 [Abstract]  
  • Jonker, J. W., Schinkel, A. H. (2004). Pharmacological and Physiological Functions of the Polyspecific Organic Cation Transporters: OCT1, 2, and 3 (SLC22A1-3). J. Pharmacol. Exp. Ther. 308: 2-9 [Abstract] [Full Text]